ASP Isotopes (NASDAQ:ASPI – Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.13), FiscalAI reports. The firm had revenue of $5.12 million for the quarter, compared to the consensus estimate of $5.68 million. ASP Isotopes had a negative net margin of 427.98% and a negative return on equity of 64.99%.
ASP Isotopes Stock Performance
Shares of ASPI stock traded down $0.20 during trading hours on Monday, reaching $1.54. The company had a trading volume of 4,475,844 shares, compared to its average volume of 4,713,274. The business has a fifty day moving average price of $2.57 and a 200-day moving average price of $4.59. ASP Isotopes has a one year low of $1.53 and a one year high of $8.60. The firm has a market cap of $236.10 million, a PE ratio of -1.17 and a beta of 3.77. The company has a debt-to-equity ratio of 0.76, a quick ratio of 3.85 and a current ratio of 3.87.
Insider Activity at ASP Isotopes
In related news, CFO Heather Kiessling sold 21,830 shares of the firm’s stock in a transaction that occurred on Friday, October 16th. The shares were sold at an average price of $2.19, for a total value of $47,807.70. Following the transaction, the chief financial officer owned 1,504,422 shares of the company’s stock, valued at approximately $3,294,684.18. This trade represents a 1.43% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Robert Ainscow sold 25,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $3.90, for a total transaction of $97,500.00. Following the sale, the chief operating officer owned 2,256,879 shares of the company’s stock, valued at $8,801,828.10. This trade represents a 1.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 245,285 shares of company stock valued at $899,887 over the last ninety days. Company insiders own 14.40% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday, September 21st. Wall Street Zen raised shares of ASP Isotopes from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 22nd. Two analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $12.00.
View Our Latest Analysis on ASP Isotopes
About ASP Isotopes
ASP Isotopes Inc. is an advanced materials company focused on producing and commercializing enriched isotopes. Its proprietary Aerodynamic Separation Process is designed to separate isotopes and support production across a range of applications. The company’s targeted products include isotopes used in medical imaging and pharmaceuticals, semiconductor manufacturing, quantum technologies and nuclear energy. Examples include molybdenum-100, silicon-28 and ytterbium-176. ASP Isotopes is headquartered in the United States and has pursued isotope-enrichment operations in South Africa.
Read More
- Five stocks we like better than ASP Isotopes
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.
